Jade Biosciences Inc.

NASDAQ: JBIO · Real-Time Price · USD
7.33
0.56 (8.27%)
At close: Aug 15, 2025, 3:59 PM
7.30
-0.48%
After-hours: Aug 15, 2025, 07:20 PM EDT

Jade Biosciences Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-70.26M -85.24M -87.94M -63.16M -39.98M -19.56M
Depreciation & Amortization
64K 84K 109K 81K 53K 25K
Stock-Based Compensation
27K 27K n/a n/a n/a n/a
Other Working Capital
-2.44M 7.76M 3.23M 3.04M 7.83M 3.51M
Other Non-Cash Items
9.26M 10.63M 11.36M 8.18M 4.74M 2.43M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.05M 8.8M 1.96M 815K 4.77M 1.5M
Operating Cash Flow
-61.95M -65.71M -74.52M -54.08M -30.41M -15.61M
Capital Expenditures
n/a -64K -96K -96K -96K -32K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
-19.68M -47.47M -90.39M -90.39M -75.64M -47.85M
Sales Maturities Of Investments
75.71M 96.08M 109.83M 91.83M 68.25M 34.75M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
56.03M 48.55M 19.35M 1.35M -7.48M -13.13M
Debt Repayment
95M 95M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-250K -250K n/a n/a n/a n/a
Financial Cash Flow
120.18M 120.09M 25.33M 954K 483K 20K
Net Cash Flow
98.18M 86.86M -29.83M -51.78M -37.41M -28.72M
Free Cash Flow
-61.95M -65.77M -74.61M -54.18M -30.51M -15.64M